How to pay the least
Ask for the cash price
Tazverik
We didn’t find one.
- Ask your pharmacy for Tazverik’s cash price, and one or two other pharmacies too.
Compare every option
Details for each option
Brand nameNo maker’s card
We didn’t find a savings card or cash price from Tazverik’s maker. Ask the pharmacy for Tazverik’s cash price. With insurance, ask what your plan charges.
Authorized genericNot sold
There isn’t one. An authorized generic is Tazverik itself, from the same company, sold without the brand name, and usually for less. For now Tazverik is the only choice; ask the pharmacy for its cash price, or your plan what it charges.
Regular genericNot sold
We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, ask the pharmacy for Tazverik’s cash price, or your plan what it charges.
What it’s used for
What the FDA label says
TAZVERIK is a methyltransferase inhibitor indicated for the treatment of:
- Adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection.
- Adult patients with relapsed or refractory follicular lymphoma whose tumors are positive for an EZH2 mutation as detected by an FDA-approved test and who have received at least 2 prior systemic therapies.
- Adult patients with relapsed or refractory follicular lymphoma who have no satisfactory alternative treatment options.
These indications are approved under accelerated approval based on overall response rate and duration of response. Continued approval for these indications may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
Source: the FDA label for Tazverik (Epizyme, Inc.), April 29, 2026. Full label on DailyMed
Good to know
- We didn’t find a savings card from Tazverik’s maker.
- Don’t stop or change a medicine without talking to your pharmacist or prescriber.
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/tazverik/